Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NAIP pseudogene 1 (NAIPP1) is a non-coding pseudogene related to the NLR family apoptosis inhibitory protein (NAIP) gene, found in a region of the genome with multiple NAIP copies and complex genetic rearrangements. Unlike the functional NAIP gene, which encodes a protein involved in inhibiting apoptosis and innate immune response, NAIPP1 is not believed to encode a functional protein. There is speculation that NAIPP1 may function as a competing endogenous RNA (ceRNA) that helps regulate neuronal NAIP transcripts and modulate inflammasome activation in neurons, but this has not been confirmed experimentally[3]. NAIPP1 is not considered a therapeutic target, nor does it fit in well-established molecular target categories such as receptor, enzyme, or transporter. Most available data focus on the functional NAIP gene, not NAIPP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NAIP pseudogene 1 (NAIPP1).